Controlling PI resistance like a switch: MDR1 and p-glycoprotein
2nd International Workshop on HIV & Women, 9-10 January 2012, Bethesda, USA 1 February 2012
Similar efficacy and a few gender related differences in side effects with rilpivirine vs efavirenz at 96-weeks 1 February 2012
Volume 13 Number 1/2 January/February 2012 1 February 2012
Supplement: HIV testing and risks of sexual transmission 1 February 2012
RSS Atom • ISSN 1472-4683 • Subscribe • About
Proteins for dummies: GMHC Treatment Issues provides a primer on how proteins work in the body — and in HIV — and how mutations can cause drug resistance.
Links to external websites are current at time of posting but not maintained.
HIV i-Base
Treatment phoneline: 0808 800 6013 • Mon-Wed 12-4pm • Office: 020 7407 8488 • Email: admin@i-base.org.uk • Website: www.i-base.info